Publications
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial2015 | Publication without faculty affiliation
- Rare myxoid liposarcoma metastasis to the interventricular septum of the heart2014 | Second Faculty of Medicine
- Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas2012 | First Faculty of Medicine, Second Faculty of Medicine
- Orphan drugs and their usage in oncology2012 | Second Faculty of Medicine
- Pazopanib in the treatment of renal cell carcinoma2012 | Second Faculty of Medicine
- Staging of non-Hodgkin's lymphoma - Recommendations of the Czech Lymphoma Study Group2010 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristcs of human mammary tumors2009 | First Faculty of Medicine, Second Faculty of Medicine
- Clinical, pathological and molecular characteristics of newly diagnosed breast cancers2007 | Second Faculty of Medicine, Central Library of Charles University
- Preoperative radiotherapy for locally advanced rectal cancer and prognostic factors influencing outcome2006 | Second Faculty of Medicine
- Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early-stage luminal breast cancer2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...